The BCA Advanced Therapies Network is a national network of over 60 members with hundreds of facilities throughout the United States with a mission to provide critical products and services for next generation cell and gene therapies.


Members of BCA’s Advanced Therapies Network supply blood tissue-based materials and custom services to innovators and health care providers of advanced therapies and related technologies around the world.


The BCA Advanced Therapies Network is not a broker; it is a cooperative of members who have committed to work collaboratively to serve the biopharma, medical device, and healthcare innovators around the world.

Whether starting from a single center collaboration and expanding to a national multi-center contract or from a national master service agreement capable of expanding to meet evolving needs, advanced therapies customers access a comprehensive, nimble network offering access to hundreds of facilities and the option of a single point of contact for contracts, billings, risk mitigation, secondary sourcing, administration, training, and more. Scalability, flexibility, and expertise dedicated to optimizing solutions are the hallmarks of the BCA AT Network.